Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma

PURPOSE: Definitive radiation therapy is the mainstay of treatment for early stage laryngeal squamous cell carcinoma (LSCC). However, up to 30% of the patients do not respond to radiotherapy. Unfortunately, we are unable to predict which tumors are likely to respond to radiation, and which will be r...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Transl Med
Hoofdauteurs: Maia, Danielle, de Carvalho, Ana Carolina, Horst, Maria Aderuza, Carvalho, André Lopes, Scapulatempo-Neto, Cristovam, Vettore, Andre Luiz
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2015
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533949/
https://ncbi.nlm.nih.gov/pubmed/26264462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0621-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items